WHO offers national assessment Checklist for the Multisectoral Accountability Framework for TB (MAF-TB)

01 April 2020 – Tuberculosis (TB) is a major yet preventable global health problem, with an estimated 10 million new cases worldwide in 2018, resulting in more than 1.5 million deaths, making it the leading infectious disease cause of death worldwide. An estimated one-fourth of the world’s population is infected with the TB bacterium, of whom 5–10% advance to active TB disease in their lifetime.

The World Health Organization (WHO) Global TB Program released a special edition of its newsletter in commemoration of World TB Day, 24 March.

The World Health Organization (WHO) Global TB Program is the Secretariat of the WHO Civil Society Task Force on TB. The aim of the Task Force is to intensify the voice of civil society in ending TB at all levels.

20 March 2020 | GENEVA: As the world comes together to tackle the COVID-19 pandemic, it is important to ensure that essential health services and operations are continued to protect the lives of people with TB and other diseases or health conditions. Health services, including national programmes to combat TB, need to be actively engaged in ensuring an effective and rapid response to COVID-19 while ensuring that TB services are maintained.

WHO advocacy and communications package to support awareness building and drive action across all levels, in the lead up to and on World TB Day.

The World Health Organization issues a Rapid Communication announcing a number of updates to its latest guidance on TB preventive treatment.

07 February 2020 | GENEVA - Member States during the 146th session of the World Health Organization (WHO) Executive Board, reviewed a  progress report on the implementation of the End TB Strategy and put forward a resolution to the World Health Assembly adopting a new global strategy for tuberculosis (TB) research and innovation.

The World Health Organization (WHO) Global TB Program, in close collaboration with the Global Fund to Fight AIDS, Tuberculosis and Malaria, the United States Agency for International Development (USAID) and the Global Drug Facility of the Stop TB Partnership have updated the Frequently Asked Questions (FAQs) document on WHO’s Rapid Communication: Key changes to the treatment of drug-resistant tuberculosis.

Two new reports of the World Health Organization reveal a weak pipeline for antibiotic agents.